Literature DB >> 26071438

GeneXpert MTB/RIF assay as initial test for diagnosis of tuberculous meningitis.

Poojan Shrestha1, Buddhi Paudyal2, Buddha Basnyat3.   

Abstract

Tuberculous meningitis (TBM) remains the most dangerous form of tuberculosis with high mortality and potential complications. The prompt diagnosis and treatment of this condition remains a key for better prognosis. A 39-year-old woman presented with severe headache, fever, nausea and vomiting, with a history of headache for a month. On examination, confusion, neck rigidity, ptosis and upward plantar reflexes were present. After 7 days of empiric treatment without resolution of her symptoms, she had another spinal tap performed. The diagnosis of TBM was performed by the GeneXpert MTB/RIF assay from her cerebrospinal fluid (CSF). Antitubercular chemotherapy was started. The patient subsequently improved. Where available, the GeneXpert assay should be used immediately in CSF samples of patients suspected of TBM as an adjunct to clinical algorithms to increase the chance of a prompt diagnosis and treatment. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26071438      PMCID: PMC4480084          DOI: 10.1136/bcr-2014-207502

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  Improving the bacteriological diagnosis of tuberculous meningitis.

Authors:  Guy E Thwaites; Tran Thi Hong Chau; Jeremy J Farrar
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Tuberculosis diagnosis--time for a game change.

Authors:  Peter M Small; Madhukar Pai
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

Review 3.  Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome.

Authors:  Flavia Brancusi; Jeremy Farrar; Dorothee Heemskerk
Journal:  Future Microbiol       Date:  2012-09       Impact factor: 3.165

4.  Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay.

Authors:  Stephen D Lawn; Alimuddin I Zumla
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

5.  Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.

Authors:  Guy E Thwaites; Duc Bang Nguyen; Huy Dung Nguyen; Thi Quy Hoang; Thi Tuong Oanh Do; Thi Cam Thoa Nguyen; Quang Hien Nguyen; Tri Thuc Nguyen; Ngoc Hai Nguyen; Thi Ngoc Lan Nguyen; Ngoc Lan Nguyen; Hong Duc Nguyen; Ngoc Tuan Vu; Huu Hiep Cao; Thi Hong Chau Tran; Phuong Mai Pham; Thi Dung Nguyen; Kasia Stepniewska; Nicholas J White; Tinh Hien Tran; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

6.  Tuberculous meningitis: a 30-year review.

Authors:  S J Kent; S M Crowe; A Yung; C R Lucas; A M Mijch
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

Review 7.  Corticosteroids for managing tuberculous meningitis.

Authors:  K Prasad; M B Singh
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

8.  Tuberculous meningitis: a uniform case definition for use in clinical research.

Authors:  Suzaan Marais; Guy Thwaites; Johan F Schoeman; M Estée Török; Usha K Misra; Kameshwar Prasad; Peter R Donald; Robert J Wilkinson; Ben J Marais
Journal:  Lancet Infect Dis       Date:  2010-09-06       Impact factor: 25.071

9.  Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India.

Authors:  Gerardo Alvarez-Uria; Jose M Azcona; Manoranjan Midde; Praveen K Naik; Srinivasulu Reddy; Raghuprakash Reddy
Journal:  Tuberc Res Treat       Date:  2012-08-26

10.  Aetiologies of central nervous system infections in adults in Kathmandu, Nepal: a prospective hospital-based study.

Authors:  Abhishek Giri; Amit Arjyal; Samir Koirala; Abhilasha Karkey; Sabina Dongol; Sudeep Dhoj Thapa; Olita Shilpakar; Rishav Shrestha; Le van Tan; Bkrong Nguyen Thi Thuy Chinh; Radheshyam Krishna K C; Kamal Raj Pathak; Mila Shakya; Jeremy Farrar; H Rogier Van Doorn; Buddha Basnyat
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.